{"id":"https://openalex.org/W4384401141","doi":"https://doi.org/10.1111/bcp.15854","title":"Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL\u2010286, a novel retinoic acid receptor\u2010\u03b2 agonist for treatment of spinal cord injury, in male healthy participants","display_name":"Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL\u2010286, a novel retinoic acid receptor\u2010\u03b2 agonist for treatment of spinal cord injury, in male healthy participants","publication_year":2023,"publication_date":"2023-07-15","ids":{"openalex":"https://openalex.org/W4384401141","doi":"https://doi.org/10.1111/bcp.15854","pmid":"https://pubmed.ncbi.nlm.nih.gov/37452623","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10835503"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.15854","doi":"https://doi.org/10.1111/bcp.15854","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.15854","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15854","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15854","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076287738","display_name":"Maria Beatriz C.V. Goncalves","orcid":"https://orcid.org/0000-0002-8817-3058","observed_orcids":["https://orcid.org/0000-0002-8817-3058"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria B. Goncalves","raw_affiliation_strings":["Neuroscience Drug Discovery Unit The Wolfson Centre for Age\u2010Related Diseases, King's College London, Guy's Campus  London UK","Neuroscience drug discovery unit, The Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, SE1 1UL UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit The Wolfson Centre for Age\u2010Related Diseases, King's College London, Guy's Campus  London UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Neuroscience drug discovery unit, The Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, SE1 1UL UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046991927","display_name":"Tim Mant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Tim Mant","raw_affiliation_strings":["NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust  London UK","NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust, 16th Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust  London UK","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I183935753","https://openalex.org/I200166805"]},{"raw_affiliation_string":"NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust, 16th Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT UK","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I183935753","https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083601745","display_name":"J\u00f6rg T\u00e4ubel","orcid":"https://orcid.org/0000-0002-0010-207X","observed_orcids":["https://orcid.org/0000-0002-0010-207X"]},"institutions":[{"id":"https://openalex.org/I4405266923","display_name":"Richmond Pharmacology Limited (United Kingdom)","ror":"https://ror.org/00c1ht118","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405266923"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J\u00f6rg T\u00e4ubel","raw_affiliation_strings":["Richmond Pharmacology Limited  London UK","Richmond Pharmacology Limited, 1A Newcomen Street, London Bridge, London, SE1 1YR UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Richmond Pharmacology Limited  London UK","institution_ids":["https://openalex.org/I4405266923"]},{"raw_affiliation_string":"Richmond Pharmacology Limited, 1A Newcomen Street, London Bridge, London, SE1 1YR UK","institution_ids":["https://openalex.org/I4405266923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024204708","display_name":"Earl E. Clarke","orcid":"https://orcid.org/0000-0001-7046-7974","observed_orcids":["https://orcid.org/0000-0001-7046-7974"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Earl Clarke","raw_affiliation_strings":["Neuroscience Drug Discovery Unit The Wolfson Centre for Age\u2010Related Diseases, King's College London, Guy's Campus  London UK","Neuroscience drug discovery unit, The Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, SE1 1UL UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit The Wolfson Centre for Age\u2010Related Diseases, King's College London, Guy's Campus  London UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Neuroscience drug discovery unit, The Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, SE1 1UL UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077734270","display_name":"Hana Hassanin","orcid":"https://orcid.org/0000-0002-1492-3653","observed_orcids":["https://orcid.org/0000-0002-1492-3653"]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hana Hassanin","raw_affiliation_strings":["Surrey Clinical Research Centre University of Surrey  Surrey UK","Surrey Clinical Research Centre, University of Surrey, Guildford, Surrey, GU2 7XH UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surrey Clinical Research Centre University of Surrey  Surrey UK","institution_ids":["https://openalex.org/I28290843"]},{"raw_affiliation_string":"Surrey Clinical Research Centre, University of Surrey, Guildford, Surrey, GU2 7XH UK","institution_ids":["https://openalex.org/I28290843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011521908","display_name":"Daryl Bendel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daryl Bendel","raw_affiliation_strings":["Surrey Clinical Research Centre University of Surrey  Surrey UK","Surrey Clinical Research Centre, University of Surrey, Guildford, Surrey, GU2 7XH UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surrey Clinical Research Centre University of Surrey  Surrey UK","institution_ids":["https://openalex.org/I28290843"]},{"raw_affiliation_string":"Surrey Clinical Research Centre, University of Surrey, Guildford, Surrey, GU2 7XH UK","institution_ids":["https://openalex.org/I28290843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040260420","display_name":"Henry Fok","orcid":"https://orcid.org/0000-0002-3693-7861","observed_orcids":["https://orcid.org/0000-0002-3693-7861"]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Henry Fok","raw_affiliation_strings":["NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust  London UK","NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust, 16th Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust  London UK","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I183935753","https://openalex.org/I200166805"]},{"raw_affiliation_string":"NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust, 16th Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT UK","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I183935753","https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015868104","display_name":"John Posner","orcid":"https://orcid.org/0009-0004-2285-2148","observed_orcids":["https://orcid.org/0009-0004-2285-2148"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Posner","raw_affiliation_strings":["Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science King's College London  London UK","Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London, SE1 9NH UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science King's College London  London UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London, SE1 9NH UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058496095","display_name":"Jane Holmes","orcid":"https://orcid.org/0000-0001-7123-0004","observed_orcids":["https://orcid.org/0000-0001-7123-0004"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jane Holmes","raw_affiliation_strings":["Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038778256","display_name":"Adrian Mander","orcid":"https://orcid.org/0000-0002-0742-9040","observed_orcids":["https://orcid.org/0000-0002-0742-9040"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adrian P. Mander","raw_affiliation_strings":["Centre for Trials Research Cardiff University  Cardiff UK","Centre for Trials Research, Cardiff University, 5th Floor Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Trials Research Cardiff University  Cardiff UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Centre for Trials Research, Cardiff University, 5th Floor Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064936602","display_name":"Jonathan P. T. Corcoran","orcid":"https://orcid.org/0000-0002-8390-4720","observed_orcids":["https://orcid.org/0000-0002-8390-4720"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jonathan P. T. Corcoran","raw_affiliation_strings":["Neuroscience Drug Discovery Unit The Wolfson Centre for Age\u2010Related Diseases, King's College London, Guy's Campus  London UK","Neuroscience drug discovery unit, The Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, SE1 1UL UK"],"raw_orcid":"https://orcid.org/0000-0002-8390-4720","affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit The Wolfson Centre for Age\u2010Related Diseases, King's College London, Guy's Campus  London UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Neuroscience drug discovery unit, The Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, SE1 1UL UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5046991927","https://openalex.org/A5064936602"],"corresponding_institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I183935753","https://openalex.org/I200166805"],"apc_list":{"value":4330,"currency":"USD","value_usd":4330},"apc_paid":{"value":4330,"currency":"USD","value_usd":4330},"fwci":0.8245,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.70300424,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"89","issue":"12","first_page":"3573","last_page":"3583"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10925","display_name":"Spinal Cord Injury Research","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10925","display_name":"Spinal Cord Injury Research","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.013299999758601189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spinal-cord-injury","display_name":"spinal cord injury","score":0.9950000047683716},{"id":"https://openalex.org/keywords/axon-growth","display_name":"axon growth","score":0.859000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7009999752044678},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9810000061988831},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6010000109672546},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7329999804496765},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.6690000295639038},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6340000033378601},{"id":"https://openalex.org/keywords/food-interactions","display_name":"food interactions","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7882359027862549},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6648208498954773},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6646414995193481},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6476556658744812},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5204832553863525},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4814121723175049},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4440126121044159},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4370129108428955},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.4245559871196747},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4138956069946289},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33028680086135864},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32255497574806213},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.19699224829673767},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10624191164970398},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1111/bcp.15854","doi":"https://doi.org/10.1111/bcp.15854","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.15854","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15854","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10835503","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10835503","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10835503/pdf/BCP-89-3573.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:37452623","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37452623","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:161570","doi":null,"is_oa":true,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/161570/1/bcp.15854.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/161570/1/bcp.15854.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:openaccess.sgul.ac.uk:115615","doi":null,"is_oa":true,"landing_page_url":"https://openaccess.sgul.ac.uk/id/eprint/115615/6/bcp15854-sup-0001-suppfiletmbg.docx","pdf_url":"https://openaccess.sgul.ac.uk/id/eprint/115615/1/Brit%20J%20Clinical%20Pharma%20-%202023%20-%20Goncalves.pdf","source":{"id":"https://openalex.org/S4306400552","display_name":"St George's Online Research Archive (St George's University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165862685","host_organization_name":"St George's, University of London","host_organization_lineage":["https://openalex.org/I165862685"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/bcp.15854","doi":"https://doi.org/10.1111/bcp.15854","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.15854","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15854","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2705272139","display_name":"A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury","funder_award_id":"MR/R006466/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320285","display_name":"King's College London","ror":"https://ror.org/0220mzb33"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4384401141.pdf","grobid_xml":"https://content.openalex.org/works/W4384401141.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W181079302","https://openalex.org/W182627651","https://openalex.org/W1909732837","https://openalex.org/W2003687276","https://openalex.org/W2009953287","https://openalex.org/W2021878310","https://openalex.org/W2023404406","https://openalex.org/W2030885174","https://openalex.org/W2047651855","https://openalex.org/W2050906919","https://openalex.org/W2061864733","https://openalex.org/W2064402415","https://openalex.org/W2070237777","https://openalex.org/W2106493886","https://openalex.org/W2108973870","https://openalex.org/W2163803523","https://openalex.org/W2165771381","https://openalex.org/W2265853784","https://openalex.org/W2523860877","https://openalex.org/W2528095620","https://openalex.org/W2618886012","https://openalex.org/W2777454787","https://openalex.org/W2911476305","https://openalex.org/W2912489692","https://openalex.org/W2922087845","https://openalex.org/W3047308634","https://openalex.org/W3093434759","https://openalex.org/W3201569316","https://openalex.org/W4286008396","https://openalex.org/W4296794035"],"related_works":["https://openalex.org/W4401976973","https://openalex.org/W2003453345","https://openalex.org/W2028171263","https://openalex.org/W3006690226","https://openalex.org/W2976547402","https://openalex.org/W1970929135","https://openalex.org/W7145709614","https://openalex.org/W2159623078","https://openalex.org/W4234108369","https://openalex.org/W2028198277"],"abstract_inverted_index":{"AIMS:":[0],"KCL-286":[1,51,204,242],"is":[2,26],"an":[3,166],"orally":[4],"available":[5],"agonist":[6],"that":[7,214],"activates":[8,233],"the":[9,42,63,110,128,148,176,195,230],"retinoic":[10],"acid":[11],"receptor":[12],"(RAR)":[13],"\u03b22,":[14],"a":[15,71,82,89,94,185,244],"transcription":[16],"factor":[17],"which":[18],"stimulates":[19],"axonal":[20],"outgrowth.":[21],"The":[22,68,150],"investigational":[23,196],"medicinal":[24,197],"product":[25,198],"being":[27],"developed":[28],"for":[29,248],"treatment":[30,247],"of":[31,50,132,241],"spinal":[32],"cord":[33],"injury":[34],"(SCI).":[35],"This":[36],"adaptive":[37,86],"dose":[38,76,85,97],"escalation":[39,77],"study":[40,78],"evaluated":[41,103],"tolerability,":[43],"safety":[44,140],"and":[45,47,93,113,161,173],"pharmacokinetics":[46],"pharmacodynamic":[48],"activity":[49],"in":[52,62,79,104,127,168,199,224],"male":[53],"healthy":[54,209],"volunteers":[55],"to":[56,59,145,181,187],"establish":[57],"dosing":[58],"be":[60],"used":[61],"SCI":[64],"patient":[65],"population.":[66],"METHODS:":[67],"design":[69,87],"was":[70,102,165,192,205],"double":[72],"blind,":[73],"randomized,":[74],"placebo-controlled":[75],"2":[80],"parts:":[81],"single":[83,112],"ascending":[84,96,115],"with":[88,142,189],"food":[90],"interaction":[91],"arm,":[92],"multiple":[95,114],"design.":[98],"RAR\u03b22":[99,191],"mRNA":[100],"expression":[101],"white":[105,200],"blood":[106,201],"cells.":[107,202],"RESULTS:":[108],"At":[109],"highest":[111],"doses":[116,213],"(100":[117],"mg),":[118],"no":[119],"trends":[120],"or":[121,130,138],"clinically":[122,217],"important":[123],"differences":[124],"were":[125,152],"noted":[126],"incidence":[129],"intensity":[131],"adverse":[133],"events":[134],"(AEs),":[135],"serious":[136],"AEs":[137,151],"other":[139],"assessments":[141],"none":[143],"leading":[144],"withdrawal":[146],"from":[147],"study.":[149],"dry":[153],"skin,":[154],"rash,":[155],"skin":[156],"exfoliation,":[157],"raised":[158],"liver":[159],"enzymes":[160],"eye":[162],"disorders.":[163],"There":[164],"increase":[167],"mean":[169],"maximum":[170],"observed":[171],"concentration":[172],"area":[174],"under":[175],"plasma":[177,219],"concentration-time":[178],"curve":[179],"up":[180],"24":[182],"h":[183],"showing":[184],"trend":[186],"subproportionality":[188],"dose.":[190],"upregulated":[193],"by":[194,208],"CONCLUSION:":[203],"well":[206],"tolerated":[207],"human":[210],"participants":[211],"following":[212],"exceeded":[215],"potentially":[216],"relevant":[218],"exposures":[220],"based":[221],"on":[222],"preclinical":[223],"vivo":[225],"models.":[226],"Target":[227],"engagement":[228],"shows":[229],"drug":[231],"candidate":[232],"its":[234],"receptor.":[235],"These":[236],"findings":[237],"support":[238],"further":[239],"development":[240],"as":[243],"novel":[245],"oral":[246],"SCI.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2023-07-16T00:00:00"}